Clinical trial
Dietary Intervention in Follicular Lymphoma
NCT00455416 · Oslo University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00455416 |
|---|---|
| Title | Dietary Intervention in Follicular Lymphoma |
| Official title | Dietary Intervention in Stage III/IV Follicular Lymphoma. Impact on Markers of Cell Proliferation, Apoptosis, Host Immune Cell Infiltrate and Oxidative Stress. |
| Acronym | KLYMF |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | University of Oslo |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Follicular Lymphoma |
| Intervention type | Drug |
| Interventions | Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)), Selenium (L-Selenomethionine), Garlic extract (Allicin), Pomegranate juice (ellagic acid), Grape juice (resveratrol, quercetin), Green Tea (Epigallocathechin gallate) |
| Enrollment | 45 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 3, 2007 |
| Last update posted | May 21, 2008 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: